23 September 2024
We are pleased to announce the nomination of eight new members to the Medicines Patent Pool (MPP)’s Community Advisory Panel (CAP). These esteemed individuals bring a wealth of experience and expertise in various fields, and we are confident that their contributions will be invaluable to our mission.
The new CAP members are:
The CAP plays a crucial advisory role for MPP and its Expert Advisory Group (EAG), offering valuable insights and guidance based on the lived experiences of its members. CAP members provide advice on challenges and opportunities relating to access in LMICs, specific medical technologies, MPP’s annual prioritisation work, and potential new priority areas. Additionally, they may at times support the EAG ensuring community and end-user perspectives are considered in their work.
We look forward to their active participation and the positive impact they will have on our initiatives.
Access our CAP page
Access our Governance page
More information about MPP’s new CAP members:
Nadia Adingra, Côte d’Ivoire (health area: HIV): Nadia Adingra is an activist with over a decade of experience in fighting HIV in Côte d’Ivoire, focusing on supporting women, young girls, and adolescents. She serves on the Board of Directors of ICWWA, is the Country Coordinator for ICW Côte d’Ivoire, and is involved in various working groups and coalitions related to HIV and TB.
Aggrey Aluso, Kenya (health area: Pandemic Preparedness and Response): Aggrey Aluso is the Director for Africa at the Pandemic Action Network (PAN) and Executive Director of Resilience Action Network Africa (RANA), focusing on Africa-centric resilience, pandemic preparedness, climate change, and global health governance. With over 20 years of experience in social justice advocacy, he has held significant roles at various organisations and holds an advanced degree in Gender and Development from the University of Nairobi.
Ibrahima Ba, Senegal (health area: HIV): Ibrahima Ba is the Director of the Bokk Yakaar Association in Fatick, Senegal. With over 15 years of experience in the fight against HIV, he coordinates interventions to improve the quality of life for people living with HIV (PLHIV) and advocates for access to new treatments.
Simon Beddoe, India (health area: viral hepatitis): Simon Wallington Beddoe is a Hepatitis C survivor and advocate with over 20 years of experience in Drug Use, Harm Reduction, HIV, and viral hepatitis across South and Southeast Asia. He has coordinated NACO’s HIV Prevention Programs in India, played a key role in Alliance India’s Harm Reduction Programme, and has been actively involved in high-level advocacy and community groups, including ANPUD and NAPUD.
Mohamed Dadsi, Morocco (health area: HIV): Mohamed Dadsi has extensive experience in community health and HIV/AIDS advocacy. He has been involved in various training programs related to strategic planning, quality assurance in HIV testing, and community engagement.
Carol Nawina, Zambia (health area: diabetes type 2 & HIV): Carol Nawina is a renowned international TB/HIV and more recently NCD activist, a passionate community representative who uses her personal experience with TB/HIV/NCDs. She is the Executive Director of CITAMplus, an NGO based in Zambia.
Shree Aman Shukla, India (health area: PrEP): Shree Aman Shukla is a dedicated advocate for health equity, focusing on LGBTQ+ communities in India and globally, with expertise in TB, HIV, PrEP, and hepatitis. Currently, they are the COO of the TWEET Foundation, a board member of the Key and Vulnerable Populations Delegation to the Stop TB Partnership, and the founder of YOUNITE Global, empowering young leaders to advocate for tuberculosis elimination.
Yashwinder Singh, India (health area: PrEP): Yashwinder Singh (Lisa) is a public health expert with over two decades of experience in HIV, viral hepatitis, and TB, and has significantly contributed to community health among LGBTQ and marginalised groups. She founded the Transgender Drug Experience Exchange (TDeX), has worked on various international health projects, and was a key activist in the historic IPC 377 case in India.
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.